New derivatives of the closo-decaborate anion [B10H9–O(CH2)2O(CH2)3C(O)–L–OCH3]2− (An) (1: L = Trp; 2: L = His; 3: L = Met; 4: L = Ala(2-oxopyrrolidin-3-yl) (Pld) were synthesized and isolated as tetraphenylphosphonium salts (Ph4P)2An. Anions 12−; 22−; 32−, and 42− contain a pendant functional group from the L-tryptophan methyl ester, L-histidine methyl ester, L-methionine methyl ester, or methyl 2-amino-3-(2-oxopyrrolidin-3-yl)propanoate (-Trp–OCH3, -His–OCH3, -Met–OCH3, or -Pld–OCH3) residue, respectively, bonded with the boron cluster anion through the oxybis[(ethane-2,1-diyl)oxy] spacer. This pacer is formed as a result of the nucleophilic opening of the attached dioxane molecule in the [B10H9O(CH2)4O]− starting derivative. Sodium salts of the target compounds were isolated and used in biological experiments. It was established that among compounds Na2An (An = 1–4), not all are capable of inhibiting the cytopathic effect of the virus in vitro. Sodium salts Na2An have a low toxic effect on a monolayer of continuous canine embryonic kidney (MDCK) cell line. Compounds Na21 and Na22 had IC50 of 5.0 and 20.0 μg/mL, respectively, while for compounds Na23 and Na24, IC50 values could not be achieved at the concentrations studied. The studies performed for molecular docking of the anionic part of 12− and 22− with the transmembrane domain of viroporin M2 show some differences in the location of these two ligands inside the M2 canal pore.
Natural polyamines (PAs) are involved in the processes of proliferation and differentiation of cancer cells. Lipophilic synthetic polyamines (LPAs) induce the cell death of various cancer cell lines. In the current paper, we have demonstrated a new method for synthesis of LPAs via the multicomponent Ugi reaction and subsequent reduction of amide groups by PhSiH3. The anticancer activity of the obtained compounds was evaluated in the A-549, MCF7, and HCT116 cancer cell lines. For the first time, it was shown that the anticancer activity of LPAs with piperazine fragments is comparable with that of aliphatic LPAs. The presence of a diglyceride fragment in the structure of LPAs appears to be a key factor for the manifestation of high anticancer activity. The findings of the study strongly support further research in the field of LPAs and their derivatives.
The emergence of drug-resistant influenza virus strains necessitates the development of novel antiviral agents with unique mechanisms of action. This study presents the synthesis and in vitro evaluation of a new class of antiviral compounds: sodium salts of amino acid ester conjugates based on the closo-dodecaborate anion [B12H12]2−, linked via a tetrahydropyran-derived spacer (Na2[B12H11O(CH2)6C(O)X], where X = L-Trp-OMe (Na22); L-His-OMe (Na23); L-Met-OMe (Na24); Pld-OMe (Na25)). The antiviral activity was assessed against contemporary, multidrug-resistant influenza A virus strains, including A/Cheboksary/125/2020 (H1N1)pdm09 and A/IIV-Orenburg/83/2012 (H1N1)pdm09. Cross-platform comparison revealed that the dodecaborate-tryptophan conjugate Na22 exhibited comparable efficacy to its lead decaborate analog against the Orenburg strain while demonstrating potent activity (IC50 = 5.0 µg/mL) against the Cheboksary strain with reduced susceptibility to neuraminidase inhibitors (oseltamivir; zanamivir) and complete resistance to M2 channel blockers. The histidine-based conjugate Na23 also showed significant efficacy against the Cheboksary strain, while methionine and lactam derivatives (Na24; Na25) remained inactive. This work confirms boron clusters as versatile platforms for antiviral development and establishes structure–activity relationships crucial for optimizing both B10 and B12-based therapeutics against resistant influenza strains.
29 June 2025 in Chemical Bulletin of Kazakh National University
This work investigates the reaction of tetrabutylammonium salts of [B10H10]2- and [B12H12]2- anions with tetrahydrofuran, 1,4-dioxane, and tetrahydropyran in the presence of aqueous H[BF4] and H2[SiF6] solutions. It is shown that these reactions yield mono-substituted derivatives of the closo-decaborate anion ([2-B10H9O(CH2)4]-, [2-B10H9O(CH2)4О]-, [2-B10H9O(CH2)5]-) and closo-dodecaborate anion ([B12H11O(CH2)4]-, [B12H11O(CH2)4О]-, [B12H11O(CH2)5]-) in high yields. It was proven that in the case of the [B10H10]2- anion, the reaction proceeds regioselectively, leading specifically to products with substituents in the equatorial belt of the boron cluster. The closo-dodecaborate anion derivative with an exo-polyhedral tetrahydropyran substituent was further functionalized by reaction with potassium cyanide in DMF. Studies showed that this reaction results in the opening of the cyclic substituent, forming a derivative containing a pendant cyano group attached to the boron cluster via a pentamethylene spacer. This compound can be further modified at the terminal group to obtain biologically active boron-containing derivatives, promising for use in ¹⁰B-neutron capture therapy (BNCT) of malignant tumors, as well as antimicrobial and antiviral therapy.The structures of all obtained derivatives were confirmed using a comprehensive set of modern physical and physicochemical analytical methods (elemental analysis, IR spectroscopy, multinuclear NMR spectroscopy, ESI mass spectrometry).
5 November 2022 in Bioorganic & Medicinal Chemistry
N,N′-Disubstituted bis-ureas and bis-thioureas containing a 4-(adamantan-1-yl)-1,2-phenylene spacer have been synthesized in 66–93% yields by the reaction of 4-(adamantan-1-yl)benzene-1,2-diamine with aromatic isocyanates and isothiocyanates. It has been found that no addition of a base (triethylamine) is required to achieve a high conversion within 12 h. The proposed method makes it possible to simplify the synthesis, isolation, and purification of the target compounds.